Shares of Green Organic Dutchman Holdings Ltd (OTCMKTS: TGODF) are powering higher after a minor correction from 2019 highs. A build up in the upward momentum could as well signal a bounce back on improved market sentiments.
TGODF Catalysts and Price Analysis
A bounce back in share price follows the confirmation that the Company has secured approval for the opening of a second legal cannabis retail store in Jamaica. The Company’s extraction processing services provider has also received organic certification, setting the stage for The Green Organic Dutchman Holdings to start delivering high-quality cannabis organic oils.
The Green Organic Dutchman Holdings has also secured a Health Canada license for the sale of cannabis oils, marking an important milestone in the race to diversify the current product line. The license approval comes on the heels of the Company commencing distribution of certified organic cannabis to medical patients in March.
A string of positive news helped catapult the stock to highs of $4 a share in March. While the stock did pull lower, in what appeared to be as a result of investors taking profits, the uptrend remains intact.
The Green Organic Dutchman Holdings has bounced off the $3 support level, waiting to see if the upward momentum has what it takes to fuel a rally back to this year highs. A rally followed by a close above the $4 a share resistance level, should see the stock turning bullish, with vast prospects of making a run for 52-weeks highs.
Conversely, failure to hold above the $3 support level could result in the stock plunging to where it started the year at the $2 level.
What Does The Green Organic Dutchman Holdings Do?
The Green Organic Dutchman Holdings casts itself as a cannabinoid-based research and development company. The Company produces organic cannabis products including organic dried cannabis, cannabis oils as well as edibles and seeds for medical applications.
Jamaica Expansion Drive
The Green Organic Dutchman Holdings is a potential bounce-back play as a string of positive development continue to strengthen the stock’s market sentiments. For starters, the Company is in the process of expanding its footprint in Jamaica following the approval of a second retail store.
The new store is located at the Montego Bay, a popular tourist destination, where the Company remains well positioned to generate significant amount of sales. In partnership with its Jamaican partner Epican Medicinal, The Green Organic Dutchman Holdings intends to open additional herb houses in the island, to service the strong demand for cannabis products.
“Our Kingston location witnessed increasing sales volumes; setting the stage for the grand opening of an Epic a Herb House in Jamaica’s largest tourist hub. It is an important milestone toward further expansion for Epican and TGOD in Jamaica,” commented Brian Athaide CEO of TGOD.
Organic Certification Milestones
The Green Organic Dutchman Holdings has also received a significant boost on its bid to develop and make available a wide array of cannabis products. Its extraction processing services provider Valens GroWorks Corp has secured an organic certification.
With the certification, the extraction service provider will now be able to supply The Green Organic Dutchman Holdings with the much-needed cannabis extracts for developing high-quality organic oils.
In addition, the Company’s European acquisition HemPoland has also secured organic certification from Authorities in Poland. The approval opens the door for The Green Organic Dutchman Holdings to enhance extraction and formulation of high-quality hemp oils from certified organic raw materials.
“We are incredibly excited that Hem Poland’s facilities, production, and processes have received organic certification within Europe. This is a major point of differentiation that offers consumers a premium experience. We are proud to continue to deliver and execute on our global organic strategy,” added Mr. Athaide.
What Next For the Green Organic Dutchman Holdings
The current share price does not accurately reflect The Green Dutchman Holdings potential. A pullback from this year highs might as well have presented a fundamental investment opportunity for investors who missed on the initial spike.
Expansion into new markets, as well as the unveiling of new cannabis products, position the Company to generate significant revenues thus shareholder value going forward. That said the stock is a fundamental pullback play after the recent correction.
For the latest updates on TGODF and other MJ stocks, sign up below!
Disclosure: We have no position in TGODF and have not been compensated for this article.
What Do Investors See In Medical Marijuana Stock (OTCMKTS:MJNA)?
Medical Marijuana Stock (OTCMKTS:MJNA) has emerged as one of many investor’s favorite pot stocks in the legal cannabis universe in 2020. The stock is already up about 10% in 2020, demonstrating how investors have warmed up to the stock early on in the New Year.
Following a disastrous 2019, cannabis investors lost money but have also learned that their best bets are stocks with strong fundamentals. They are looking for companies that have positioned themselves well in the cannabis industry and have what it takes to go for the opportunities. That is why MJNA stock is catching a lot of investor attention in 2020 because of how it has positioned itself in the cannabis market.
Robust revenue growth and strong financial position have also helped put MJNA on the radar of investors hunting for quality cannabis stocks. Revenue at MJNA more than doubled from $26.5 million in 2017 to $60 million in 2018. MJNA is also not in financial distress as may be the case with other cannabis companies out there. The company finished the third quarter, the most recent reported period, with $5.5 million in cash reserves.
Moreover, MJNA has recently taken steps to expand into new international markets and invest in companies that are leaders in their segments. These prudent actions are helping lift Medical Marijuana stock as more investors learn about them.
About Medical Marijuana stock
Is Tilray Inc (NASDAQ:TLRY) A Buy Or Sell?
For Tilray Inc (NASDAQ:TLRY) and the rest of cannabis stocks, 2019 was no doubt a bad year. But 2020 is shaping up to be a promising year for the stock. To start with, Tilray stock has already gained 8.35% year-to-date. If that says anything, it shows following the broad selloff in Tilray stock last year, we’ve got to a point where sellers are giving way to buyers in the stock.
There are several catalysts that should continue driving NASDAQ:TLRY as you’re about to see. First, below is a brief profile of the company we’re discussing.
Tilray is a Canada-headquartered global cannabis company. It is engaged in activities of cannabis cultivation and processing as well as marketing and distribution of cannabis products. Tilray already has several cannabis products brands to its portfolio. It operates across five continents through subsidiaries in Canada, Australia, Germany, and Portugal.
Following the broad collapse of cannabis stocks in 2019, investors are looking for cannabis stocks that can make a positive impact on their portfolios in 2020. Tilray stands out as an attractive cannabis stock pick in 2020. Here are some of the exciting things about the company.
Tilray CEO sees a bright future for the cannabis industry
On January 25, Tilray CEO Brendan Kennedy spoke on Bloomberg. In that interview, Kennedy framed a rosy outlook for the…
Is Cronos Stock (TSE:CRON)(NASDAQ:CRON) A Buy?
Cronos Stock (TSE:CRON)(NASDAQ:CRON) stock fell 9.22% on January 24, marking its steepest decline so far in 2020. The stock plunge followed an important disclosure that you would only expect from a company that is trying to be straight and transparent with investors. Here’s what happened.
On January 22, after market close, Cronos made a regulatory filing detailing changes in its executive team. In that SEC filing, Cronos revealed that David Hsu and William Hilson have stepped down as its chief operating officer and chief commercial officer, respectively. Unfortunately, some investors read bad news in the executive exits and sold their shares in Cronos.
But a careful reading of the filing doesn’t seem to raise any red flags. Therefore, the big stock plunged points to investors panicking to the degree of responding to a mosquito bite with a missile.
There is no doubt that 2019 was a difficult year for cannabis stocks and Cronos Stock is no exception. But before the uncalled for reaction to Cronos’s regulatory filing, we had been at a point where sellers were starting to give way to buyers in Cronos stock. The stock has gained about 8.0% in the past one month. It had gained more than 13% year-to-date before the January 24 big selloff.
About Cronos Stock
Cronos Stock is a Canada-based global cannabis company. Cronos operates through subsidiaries and…